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Abstract
Background: Vitamin D deficiency with all its consequences is a global health problem.
Case Presentation: We reported a 62-year-old Caucasian woman with alcohol-related liver cirrhosis (Child class A)
and a medical history of Billroth II surgery. Although she has taken an oral dose of 16 800 IU vitamin D daily for six
weeks to normalise her 25-hydroxyvitamin D level the raise was only moderate.
Conclusion: High-dose oral or parenteral vitamin D therapy is necessary to gain sufficient 25-hydroxyvitamin D
serum levels in patients following gastric surgery.
Background
Vitamin D deficiency is defined as 25-hydroxyvitamin D
serum levels below 20 ng/ml; levels ≥20 and <30 ng/ml
indicate an inadequate vitamin D status. Approximately
1 billion people worldwide have 25-hydroxyvitamin D
levels below 30 ng/ml[1]. The major source of vitamin
D is sunlight, which promotes subcutaneous production
of vitamin D under the influence of UVB light; only 15-
20% of vitamin D in the body derives from food. Apart
from musculoskeletal malfunction (eg. osteomalacia,
osteoporosis, muscle weakness, falls), vitamin D defi-
ciency seems to be associated with several other dis-
eases, e.g. cancer and cardiovascular or immunological
disorders[2]. Corresponding trials demonstrated that a
daily vitamin D intake of 800-1000 IU is needed to
achieve and maintain 25-hydroxyvitamin D levels
between 70-80 nmol/l, which are considered to be opti-
mal for fracture prevention[3].
Case Presentation
A 62-year-old female Caucasian was admitted to our
endocrinology outpatient clinic for evaluation of osteo-
porosis. The patient had a history of partial gastrectomy
with Billroth II reconstruction due to multiple gastric
ulcers 27 years previously, and liver cirrhosis (Child A)
of more than 15 years’ standing due to a period of alco-
holism as well as local breast cancer in 2003. For
treatment of portal hypertension and recurrent ascites,
she was being treated with propranolol, furosemide and
spironolactone.
A fasting blood sample taken the morning after
admission produced the following results: elevated liver
transaminases (GGT 242 U/l [<38], AST 49 U/l [<30]),
but unimpaired liver function. Blood count and other
parameters were within normal limits. Specific analysis
showed low 25-hydroxyvitamin D (20 ng/ml [30.0-60.0])
with normal serum PTH, but elevated levels of bone-
specific alkaline phosphatase (74.3 μg/l [7.1-21.3]) and
b-Crosslaps (0.53 ng/ml [0.09-0.44]), reflecting acceler-
ated bone turnover. Standardized x-ray of the spine
showed hyperkyphosis but no fractures. DXA measure-
ment at the spine and the hip revealed osteopenia with
a T-score of -1.8 SD and -2.0 SD, and osteoporosis at
the distal forearm with a T-score of -2.8 SD.
The patient was advised to take an oral dose of 16 000
IU (40 drops) of vitamin D 3 per week combined with a
daily supplement of 1000 mg calcium and 800 IU vita-
min D 3.
At 6 weeks’ follow-up, she reported that she had taken
40 drops of vitamin D 3 daily, resulting in a cumulative
intake of 705 600 IU in that period. Blood analysis then
showed 35 ng/ml 25-hydroxyvitamin D, with a surpris-
ingly small increase of 15 ng/ml.
Discussion
Oral treatment with 1000 IU vitamin D daily over a per-
iod of 3-4 months raises 25-hydroxyvitamin D by about
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would be expected with a daily vitamin D intake of 16
800 IU. The increase of just 15 ng/ml was a surprise.
The history of Billroth II may, however, have had a
negative impact on absorption, although the enteral
absorption of the fat-soluble vitamin D takes place in
the duodenum and the proximal jejunum, sections of
the gut that are not removed as part of a Billroth II
resection.
The exact mechanism of the development of vitamin
D deficiency in patients following gastric surgery is not
yet known. Malabsorption due to accelerated intestinal
passage, impaired secretion of pancreatic enzymes and
bacterial overgrowth may lead to steatorrhea [5] and so
to avoidance of food rich in vitamin D, which could also
contribute to vitamin D deficiency[6].
Conclusion
Vitamin D toxicity has recently become a controversial
issue. According to the literature, a vitamin D intake of
10 000 IU daily does not cause intoxication in the sense
of 25-hydroxyvitamin D levels above 150 ng/ml asso-
ciated with hypercalcemia and hyperphosphatemia, even
in healthy people[1,7]. Some special groups of patients
may need even higher doses of supplementation to
achieve satisfactory serum vitamin D levels. This case
demonstrates that patients with a history of gastrointest-
inal surgery may need either high-dose oral vitamin D
supplementation or even parenteral administration.
Consent
Written informed consent was obtained from the patient
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images. A copy of the written consent is available for
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